NEWARK, Del:, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Europe Dermal filler Market are anticipated to increase significantly over the next few years due to a number of factors, such as the rising popularity of minimally invasive surgical procedures, technological developments that have allowed for the creation of novel products that can be used in combination therapies, partnerships between major dermal filler producers and specialised clinics, and online marketing campaigns.
The Europe market currently stands at US$ 1.63 Billion in 2022, and it is further projected to expand at a CAGR of 4.5% over the forecast period (2023-2033).
Download the PDF Sample of European Dermal Fillers Market Overview Now! @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17858
The market expansion is being considerably fueled by a rising demand for less invasive cosmetic operations across practically all European demographic groups, according to recent industry trends. To improve their looks, men in particular have become more interested in skin-improving operations. Men are also aware of how ageing affects their skin and their facial features. More men in Europe are looking for novel ways to stop the effects of early gravitational ageing, which mostly affects the skin of the face, thanks to their unparalleled access to social media and other resources.
In order to create credibility and broaden the appeal of their products, manufacturers are increasingly concentrating on partnering with recognized cosmetic clinics and healthcare professionals in the aesthetic area. Joint marketing initiatives, educational initiatives, and exclusive distribution contracts are examples of partnerships.
Marketing and advertisement, advancing medical infrastructure as well as the rise in medical tourism in Europe are all such factors that are anticipated to grow the market of dermal fillers in Europe.
Key Takeaways from Market Study
- By ingredient, the hyaluronic acid segment contributed around US$ 1.1 Billion in 2022. Due to its great biocompatibity, versatility, and natural and long-lasting effects hyaluronic acid has been a constant favorite among consumers and practitioners.
- By product, absorbable dermal fillers contributed around US$ 1.6 Billion in 2022. Its high safety profile, natural-looking results and slow breakdown to avoid any sudden adverse change to the body are the major growth factors.
- By application, aesthetic restoration contributed around US$ 1.3 Billion in 2022, owed to the efficiency of dermal filler techniques in treating various ageing symptoms and improving natural characteristics
- By end users, specialty clinics contributed around US$ 1.4 Billion in 2022, due to the increasing number of advanced clinics and customized treatment solutions
- By country, Germany held the dominant share in the world in 2022 with the U.S. contributing around 33.3% value share. Given its continuous technological improvements, rising aesthetic awareness, and advanced clinic infrastructure, Germany dominated the Europe dermal filler market.
Save Up to 30%. Report Customization by selecting specific countries or regions. Specify Your Scope! https://www.futuremarketinsights.com/customization-available/rep-gb-17858
“Increased adoption of minimally invasive procedures backed by novel scientific formulations leading to a younger looking skin and social media influence will boost the growth of the Europe dermal filler market,” says an analyst of Future Market Insights.
Top 14 Key Players in Europe Dermal Fillers Market and Their Marketing Strategy
The dermal filler market is moderately competitive in Europe. The market leaders are in a constant run to further establish their position by product launches and collaborations, which has inspired the upcoming players to follow their market footprints.
- In June 2023, Croma unveiled PhilArt, an extensive array of injectable skin enhancers. The injectable gel PhilArt, which is based on long-chain polynucleotides (PN), improves radiance via rejuvenation, restores the skin's suppleness, encourages hydration and scavenges free radicals, fosters the formation of fibroblasts and fibres, and stimulates the body's cell regeneration.
The key market players involved are:
- Galderma Pharma S.A
- Bioscience GmbH
- Croman Pharma
- Allergan plc. (AbbVie)
- Sinclair Pharma plc. (Heading Medicine Co., Ltd)
- Zimmer Aesthetics
- Mars Pharma GmbH & Co. Kraal
- Zueva Medical, Inc.
- Texan Laboratories Inc.
- Adder GmbH
- Polonium Medical Technologies Inc.
- Intracellular Medical UK Ltd
- LKC Pharma
- Biloxi’s Pharmaceutical
Awaken your strategic prowess with our Competition Deep Dive. Purchase now to unravel the mysteries of sales footprints and shape your product strategy! https://www.futuremarketinsights.com/checkout/17858
Key Market Segments Covered in Europe Dermal Fillers Industry Research
By Ingredient:
- Hyaluronic Acid
- Poly-L-Lactic Acid
- Calcium Hydroxylapatite
- Polymethyl methacrylate
- Collagen
- Polynucleotide (PN)
By Product Type:
- Absorbable
- Non-absorbable
By Application:
- Aesthetic Restoration
- Dentistry
- Reconstructive Surgery
By Distribution Channel:
- Hospitals
- Specialty Clinics
- Small
- Medium
- Large
- Online Pharmacies
By Country:
- United Kingdom
- Germany
- Spain
- Italy
- France
- BENELUX
- Nordics
- Rest of Europe
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the Europe dermal fillers market in its latest study, presenting a historical demand assessment of 2012 to 2022 and projections for 2023 to 2033. The Europe dermal fillers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader
The analysis is based on the product (absorbable, and non-absorbable), ingredient (Hyaluronic Acid, Poly-L-Lactic Acid, Calcium Hydroxylapatite, Polymethyl methacrylate, Collagen, and Polynucleotide (PN)), application (aesthetic restoration, dentistry, and reconstructive surgery), and distribution channel (hospitals, specialty clinics {small, medium, large}, and online pharmacies), across seven key countries in Europe.
Have a Look at Trending Reports in Healthcare & Materials Domain:
Hadron Therapy Market: Anticipated to attain a value of US$ 1.5 billion in 2023, the worldwide hadron therapy market is poised for remarkable growth, surging to US$ 4.7 billion by 2033. Projected at an impressive CAGR of 11.9% from 2023 to 2033, this marks a substantial increase from the 8% CAGR recorded from 2018 to 2022.
Onychomycosis Treatment Market: Anticipated at a value of US$ 4,738.3 million in 2023, the worldwide onychomycosis treatment market is poised for substantial expansion. Over the period from 2023 to 2033, the market is projected to achieve a noteworthy Compound Annual Growth Rate (CAGR) of 8.4%, reaching a total worth of US$ 10,608.8 million.
Single-use Bioreactors Market: By 2033, the single-use bioreactors market is forecasted to attain a substantial worth of US$ 18.9 billion, with a projected valuation of US$ 4.5 billion by the conclusion of 2023. Notably, the market is expected to experience a noteworthy Compound Annual Growth Rate (CAGR) of 15.4% from 2023 to 2033.
Endoscopic Closure Systems Market: The projected value of the worldwide endoscopic closure systems market for 2023 is estimated at approximately US$ 309.2 million, with a projected Compound Annual Growth Rate (CAGR) of 6.3%. It is expected to further rise and reach around US$ 570.2 million by the period between 2023 and 2033. Notably, from 2018 to 2022, the endoscopic closure systems sector demonstrated a steady expansion at a CAGR of 4.1%.
Knee Reconstruction Devices Market: By 2023, the worldwide knee reconstruction devices market is projected to achieve a value of approximately US$ 8.5 billion, showing a steady growth rate with a 4.3% CAGR from 2023 to 2033. Furthermore, the market is poised to reach around US$ 13.0 billion by the end of 2033.
Oncology Information Systems Market: The projected scale of the oncology information systems market for 2022 was approximately US$ 2,593.4 million, and it is expected to reach around US$ 2,753.8 million in 2023.
Herpes Simplex Keratitis Treatment Market: In 2022, the projected value of the herpes simplex keratitis treatment market was US$ 4,237.2 million, and this figure is expected to rise to US$ 4,442.2 million in 2023. Several pivotal factors are poised to drive growth in the herpes simplex virus treatment market.
Cell Line Development Market: The cell line development market is anticipated to achieve a value of US$ 5.06 billion in 2023, with a projected 7.7% CAGR from 2023 to 2033. The market is expected to reach US$ 10.6 billion by the end of the forecast period. In 2022, the industry was valued at US$ 4.7 billion.
Dyslexia Treatments Market: By 2033, the global dyslexia treatment market is projected to reach a value of US$ 8008.9 million, exhibiting accelerated growth from its 2023 value of US$ 4352.0 million, with a forecasted CAGR of 6.3%. Notably, between 2018 and 2022, the dyslexia treatment market demonstrated growth at a rate of 5.8%.
Mobile Endoscopic Workstations Market: The mobile endoscopic workstation market was projected to reach US$ 292.7 million in 2022 and is anticipated to grow to US$ 302.9 million in 2023. Future Market Insights predicts a steady expansion with a 4.4% CAGR from 2023 to 2033, leading to an estimated valuation of approximately US$ 465.8 million by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
